专题论文

肠道微生物样本库:伦理考量和管理规范

  • 马永慧 ,
  • 王军
展开
  • 1. 厦门大学医学院生命伦理研究中心, 厦门 361102;
    2. 中国科学院微生物研究所, 北京 100101
马永慧,讲师,研究方向为生命伦理学,电子信箱:yhma@xmu.edu.cn

收稿日期: 2017-08-20

  修回日期: 2017-10-19

  网络出版日期: 2017-11-16

基金资助

国家社会科学基金项目(16CZX064)

Biobanking for human gut microbiome:Ethical and regulatory considerations

  • MA Yonghui ,
  • WANG Jun
Expand
  • 1. Centre for Bioethics, Medical College, Xiamen University, Xiamen 361102, China;
    2. Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China

Received date: 2017-08-20

  Revised date: 2017-10-19

  Online published: 2017-11-16

摘要

人体微生物组与健康和疾病的关系是重要的科学问题。而人体微生物样本库的建立是人体微生物组研究的重要基础,这个新兴领域迫切要求对已建立的价值体系和伦理规范进行调整和变革。本文讨论人体微生物样本库建设中的知情同意、样本和数据的所有权、隐私和风险等;并以粪菌库和粪菌移植为典型案例,分析选择"最佳"、"健康"供体所面临的医学和伦理困难;提出了人体微生物样本库监管的政策建议。

本文引用格式

马永慧 , 王军 . 肠道微生物样本库:伦理考量和管理规范[J]. 科技导报, 2017 , 35(21) : 37 -42 . DOI: 10.3981/j.issn.1000-7857.2017.21.004

Abstract

Human microbiome research and its relationship with health and disease have increasingly become a hot area in biomedical science. Biobanking human microbiome is fundamental for the development of human microbiome research. However, human microbiome research and biobank are facing many serious ethical, social and regulatory challenges that must be addressed. In this article, we examine three core ethical and social issues, i.e., informed consent, ownership, privacy and risks. Next, we employ fecal microbiota bank and fecal microbiota transplantation as a case study to discuss how to determine a suitable healthy donor. We conclude the article by providing some regulatory and governance suggestions for policy makers to develop successful policy response.

参考文献

[1] 马永慧, 杨云生. 人体微生态研究伦理:生命伦理学的新领域[J]. 中国医学伦理学, 2017, 30(7):814-822. Ma Yonghui, Yang Yunsheng. Ethics of human microbiome research:New field for bioethics[J]. Chinese Medical Ethics Journal, 2017, 30(7):814-822.
[2] Lederberg J. The microbe's contribution to biology-50 years after[J]. International Microbiology:The Cfficial Journal of the Spanish Society for Microbiology, 2006, 9(3):155-156.
[3] Cambon-Thomsen A, Rial-Sebbag E, Knoppers B M. Trends in ethical and legal frameworks for the use of human biobanks[J]. The European Respiratory Journal, 2007, 30(2):373-382.
[4] 董尔丹, 胡海, 俞文华. 生物样本库是生物医学研究的重要基础[J]. 中国科学:生命科学, 2015, 45:359-370. Dong Erdan, Hu Hai, Yu Wenhua. Biobank is important foundation for biomedical research[J]. China Science:Life Science, 2015, 45:359-370.
[5] 朱伟. 知情同意:定义、模式和挑战[J]. 生命科学2012, 24(11):1243-1249. Zhu Wei. Informed Consent:definition, paradigm, and challenges[J]. Life Science, 2012, 24(11):1243-1249.
[6] 刘闵, 翟晓梅, 邱仁宗. 生物信息库的知情同意问题[J]. 中国医学伦理学, 2009, 22(2):31-33. Liu Min, Zhai Xiaomei, Qiu Renzong. Informe consent issues in biobank[J]. Chinese Medical Ethics Journal, 2009, 22(2):31-33.
[7] Hawkins A K, O'Doherty K C. "Who owns your poop":Insights regard-ing the intersection of human microbiome research and the ELSI as-pects of biobanking and related studies[J]. BMC Medical Genomics, 2011, 4:72.
[8] McGuire A L, Colgrove J, Whitney S N, et al. Ethical, legal, and social considerations in conducting the Human Microbiome Project[J]. Ge-nome Research, 2008, 18(12):1861-1864.
[9] Hallinan D, Friedewald M. Open consent, biobanking and data protec-tion law:Can open consent be ‘informed’ under the forthcoming data protection regulation[J]. Life Sciences, Society and Policy, 2015, 11:1.
[10] Steinsbekk K S, Kare Myskja B, Solberg B. Broad consent versus dy-namic consent in biobank research:Is passive participation an ethical problem[J]. European Journal of Human Genetics, 2013, 21(9):897-902.
[11] Mello M M, Wolf L E. The Havasupai Indian tribe case-lessons for re-search involving stored biologic samples[J]. New England Journal of Medicine, 2010, 363(3):204-207.
[12] Gligorov N, Frank L, Schwab A P, et al. Privacy, confidentiality, and new ways of knowing more in the human microbiome:Ethical, legal and social concerns[M]. New York:Oxford University Press, 2013:109-111.
[13] Schwab A P, Brenner B, Goldfarb J, et al. Biobanks and the human microbiome in the human microbiome:ethical, legal and social con-cerns[M]. New York:Oxford University Press 2013, 183-184.
[14] Rhodes R. Gligorov N, Schwab A P. The human microbiome:Ethical, legal and social concerns[M]. New York:Oxford University Press 2013:9-11.
[15] Rhodes R. Ethical issues in microbiome research and medicine[J]. BMC Medicine, 2016, 14(1):156.
[16] 曾令烽, 刘军, 潘建科, 等. 人体微生物研究和样本库建设中的伦理问题及对策[J]. 中国医学伦理学, 2015, 28(2):162-166. Zeng Lingfeng, Liu Jun, Pan Jianke, et al. Ethical issues and resolutions in human microbiome reearch and bibank[J]. Chinese Medical Ethics Journal, 2015, 28(2):162-166.
[17] Franzosa E A, Huang K, Meadow J F, et al. Identifying personal mi-crobiomes using metagenomic codes[J]. Proceedings of the National Academy of Sciences, 2015, 112(22):2930-2938.
[18] Tridico S R, Murray D C, Addison J, et al. Metagenomic analyses of bacteria on human hairs:A qualitative assessment for applications in forensic science[J]. Investigative Genetics, 2014, 5(1):1-13.
[19] 马永慧, 许鸿志, 肖传兴, 等. 粪菌移植的伦理、社会问题探讨[J]. 中华消化杂志, 2016, 36(12):861-863. Ma Yonghui, Xu Hongzhi, Xiao Chuanxing, et al. Ethical and social issues in fecal microbiota transplantation[J]. Chinese Digestive Journal, 2016, 36(12):861-863.
[20] Terveer E M, van Beurden Y H, Goorhuis A, et al. How to establish and run a stool bank[J]. Clinical Microbiology and Infection, 2017, doi:cmi.2017.05.015.
[21] Ma Y, Yang J, Cui B, et al. How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation:A questionnaire study[J]. BMC Medical Ethics, 2017, 18(1):1-11.
[22] Paramsothy S, Borody T J, Lin E, et al. Donor recruitment for fecal mi-crobiota transplantation[J]. Inflammatory Bowel Diseases, 2015, 21(7):1600-1606.
[23] Ma Y, Liu J, Rhodes C, et al. Ethical issues in fecal microbiota trans-plantation in practice[J]. The American Journal of Bioethics, 2017, 17(5):34-45.
[24] Bakken J S, Borody T, Brandt L J, et al. Fecal microbiota transplanta-tion workgroup:Treating clostridium difficileinfection with fecal micro-biota transplantation[J]. Clinical Gastroenterology & Hepatology,2011, 9(12):1044-1049.
[25] Relman D, Rustgi A K, Vender R J, et al. Joint society letter to FDAcurrent consensus guidance on donor screeningand stool testing for FMT. 2013. http://ww.gastro.org/research/Joint_society-FMT_guidance.pdf.
[26] Smits L P, Bouter K E, de Vos W M, et al. Therapeutic potential of fe-cal microbiota transplantation[J]. Gastroenterology, 2013, 145(5):946-953.
文章导航

/